BMPC Canada represents a proposed class of investors who purchased securities in various offerings of Wayland Group Corp. (“Wayland”), a vertically integrated medical marijuana company, operating a cultivation, extraction and distribution business. Plaintiff in this action alleges that Wayland, as well as its various underwriters, made various misrepresentations and omissions regarding, among other things, the state of the expansion of its Langton Facility.
Gregg Edwards was retained to provide expert testimony relating to the computation of primary market damages under common law and Section 130(1) of the OSA.
Click here for more information about this class action.
